Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETF

Article summary

Moderna shares have surged nearly 30% in five days, ahead of a key FDA advisory vote on its flu vaccine, lifting the leveraged MRNX ETF more than 60%.